To contribute to international health technology assessment and reimbursement research standards and methods, and create a forum for communication between researchers, payers and the scientific and academic communities at large.


In the development of evidence in the form of pharmacoeconomic (economic) and outcomes research studies, understanding the use of this evidence is critical in the design of outcomes research studies. However, few outcomes researchers consider the end use of the results when designing the study. It is important that outcomes researchers consider reimbursement guidelines/ protocols in the design and implementation of outcomes research studies and understand the decision-making process.

It is equally important that health care decision makers are knowledgeable of outcomes research methods and use of outcomes research study results in health care decisions. By its presence or absence, reimbursement for a new procedure, drug or medical device can dramatically affect patient care.

Working Groups:

Key Project

Accepting new proposals for key projects. Interested members can contact us with proposal recommendations.

Other Related Resources

  • The ISPOR Global Health Care Systems Road Map
  • HTA Around the World: Lessons Learned
  • HTA Organizations Directory
Your browser is out-of-date

ISPOR recommends that you update your browser for more security, speed and the best experience on ispor.org. Update my browser now